Elmiron Alternatives Compared
Elmiron (pentosan polysulfate sodium) | Phenazopyridine | Amitriptyline |
|
---|
Elmiron (pentosan polysulfate sodium) | Phenazopyridine | Amitriptyline |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Interstitial Cystitis, Bladder Infection. Elmiron may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Interstitial Cystitis, Dysuria. Phenazopyridine may also be used for purposes not listed in this medication guide. |
Prescription only
Amitriptyline is an effective antidepressant but it may cause drowsiness initially and a withdrawal syndrome with abrupt discontinuation. It may be used off-label to treat other conditions such as... View more |
Related suggestions Interstitial Cystitis
Popular comparisons
|
|||||||||||||||||||||||
More about Elmiron (pentosan polysulfate sodium) | More about Phenazopyridine | More about Amitriptyline | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Elmiron has an average rating of 7.2 out of 10 from a total of 107 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 22% reported a negative effect. |
Phenazopyridine has an average rating of 6.9 out of 10 from a total of 189 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 27% reported a negative effect. |
Amitriptyline has an average rating of 7.5 out of 10 from a total of 1804 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Elmiron side effects |
View all Phenazopyridine side effects |
View all Amitriptyline side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Elmiron prices |
View all Phenazopyridine prices |
View all Amitriptyline prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Azo Urinary Pain Relief, Azo-Gesic, Azo-Septic, Azo-Standard, Baridium, Eridium, Preferred Maximum Strength Urinary Pain Relief, Preferred Urinary Pain Relief, Prodium, Pyridium, Re-Azo, Uricalm, Uristat, Uristat Ultra, Uro-Pain View more |
N/A |
||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
4.8 hours |
N/A |
16 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 79 drugs are known to interact with Elmiron:
|
A total of 60 drugs are known to interact with Phenazopyridine:
|
A total of 714 drugs are known to interact with Amitriptyline:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
September 26, 1996 |
N/A |
April 07, 1961 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.